| Reduction of post-suxamethonium pain by pretreatment with four non-depolarizing agents. | |
| | |
MedLine Citation:
|
PMID: 6112998 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The frequency of post-suxamethonium pain after pretreatment with small doses of non-depolarizing neuromuscular blocking agents was studied in 299 patients. Gallamine 10 and 20 mg, tubocurarine 5 mg and pancuronium 1 mg were equally effective when a 2-min interval was allowed between their injection and suxamethonium administration. Fazadinium was ineffective and caused difficulty with intubation. No evidence supporting the concept that dosage should be related to patient's weight was found. Inpatients suffered from post-suxamethonium pain as much as did outpatients. |
| | |
Authors:
|
F E Bennetts; K I Khalil |
Related Documents
:
|
1908378 - Efficacy of adrenaline, lignocaine-adrenaline and isoprenaline as a test dose in haloth... 1209618 - Neuromuscular blocking properties of some antibiotics in man. 8821548 - Antinociceptive profile of the pseudopeptide b2 bradykinin receptor antagonist npc 1868... 8123398 - Pharmacodynamics of mivacurium in children, using a computer-controlled infusion. 2819918 - Evidence for a possible interaction between noradrenergic and serotonergic neurotransmi... 21197208 - Accidental salinomycin intoxication in calves. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: British journal of anaesthesia Volume: 53 ISSN: 0007-0912 ISO Abbreviation: Br J Anaesth Publication Date: 1981 May |
Date Detail:
|
Created Date: 1981-08-10 Completed Date: 1981-08-10 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0372541 Medline TA: Br J Anaesth Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 531-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Body Weight Female Gallamine Triethiodide / therapeutic use Humans Male Middle Aged Neuromuscular Blocking Agents / therapeutic use* Pain, Postoperative / chemically induced, prevention & control* Pancuronium / therapeutic use Premedication* Pyridinium Compounds / therapeutic use Succinylcholine / adverse effects* Tubocurarine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Neuromuscular Blocking Agents; 0/Pancuronium; 0/Pyridinium Compounds; 306-40-1/Succinylcholine; 57-95-4/Tubocurarine; 65-29-2/Gallamine Triethiodide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Plasma concentrations and clinical effects of lorazepam after oral administration.
Next Document: The role of dietary protein in hepatic lipogenesis in the young rat.